These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1934315)

  • 41. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transplasma membrane redox system in HL-60 cells is modulated during TPA-induced differentiation.
    Burón MI; Rodriguez-Aguilera JC; Alcaín FJ; Navas P
    Biochem Biophys Res Commun; 1993 Apr; 192(2):439-45. PubMed ID: 8484755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma.
    Jameela SR; Latha PG; Subramoniam A; Jayakrishnan A
    J Pharm Pharmacol; 1996 Jul; 48(7):685-8. PubMed ID: 8866329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of lonidamine on the membrane electrical properties of Ehrlich ascites tumor cells.
    Santini MT; Cametti C; Indovina PL; Malorni W; Benassi M; Gentile FP; Castiglione S; Floridi A
    FEBS Lett; 1991 Oct; 291(2):169-72. PubMed ID: 1936258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transmembrane ferricyanide reductase activity in Ehrlich ascites tumor cells.
    Medina MA; Sánchez-Jiménez F; Segura JA; Núñez de Castro I
    Biochim Biophys Acta; 1988 Dec; 946(1):1-4. PubMed ID: 3207724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of membrane-active compounds on the radiation-modifying effect of glucose in x-irradiated ascitic tumor cells].
    Obrokov AF; Letov VN; Veksler AM
    Radiobiologiia; 1991; 31(6):856-60. PubMed ID: 1767017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cycloheximide treatment modifies the pattern of "metastasis" following intravenous injection of Ehrlich ascites tumour cells.
    Parry EW
    Gan; 1981 Jun; 72(3):464-7. PubMed ID: 7319203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Inhibition of pinocytosis and of acid phosphatase activity caused by lack of serum in the culture medium of Ehrlich ascites tumor cells (author's transl)].
    Pfab R; Schachtschabel DO; Paul N; Hess F
    Strahlentherapie; 1979 Jan; 155(1):51-7. PubMed ID: 760277
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of the stress on the mitotic activity of the Ehrlich ascites tumour cells.
    Markov GG; Raitcheva E
    C R Acad Bulg Sci; 1967; 20(6):587-90. PubMed ID: 5601636
    [No Abstract]   [Full Text] [Related]  

  • 50. Gossypol inhibits Ehrlich ascites tumor cell proliferation.
    Tso WW
    Cancer Lett; 1984 Oct; 24(3):257-61. PubMed ID: 6498805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transformed liver cells have modified transplasma membrane redox activity which is sensitive to adriamycin.
    Sun IL; Crane FL; Chou JY; Löw H; Grebing C
    Biochem Biophys Res Commun; 1983 Oct; 116(1):210-6. PubMed ID: 6639658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative cytochemical investigations on Ehrlich ascites tumour cells treated with Vincristine. II. Fast green cytophotometric investigations.
    Gyeskó A; Szentirmay Z; Sugár J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(1):90-8. PubMed ID: 4263846
    [No Abstract]   [Full Text] [Related]  

  • 53. Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions.
    Castiglione S; Fanciulli M; Bruno T; Evangelista M; Del Carlo C; Paggi MG; Chersi A; Floridi A
    Anticancer Drugs; 1993 Jun; 4(3):407-14. PubMed ID: 8358069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional reconstitution of Ehrlich cell plasma membrane ferricyanide reductase.
    Medina MA; Núñez de Castro I
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1109-13. PubMed ID: 7802639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulatory effect of acid glycopeptide of Ehrlich ascites tumour on cell multiplication.
    Jodezyk KJ; Farbiszewski R; Bańkowski E; Gabryel H
    Zentralbl Allg Pathol; 1983; 127(1-2):19-23. PubMed ID: 6858422
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of a Zn(2+)-sensitive component of Ehrlich cell plasma membrane redox system by CHAPS-agarose-polyacrylamide electrophoresis and in situ staining of activity.
    Rodríguez-Caso L; Rodríguez-Agudo D; del Castillo-Olivares A; Márquez J; Núñez de Castro I; Medina MA
    Biochem Mol Biol Int; 1997 Jan; 41(1):75-81. PubMed ID: 9043637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin.
    Takabe Y; Miyamoto T; Terashima T
    Gan; 1974 Dec; 65(6):559-60. PubMed ID: 4142871
    [No Abstract]   [Full Text] [Related]  

  • 58. Growth acceleration of Ehrlich ascites tumor cells treated by proteinase in vitro.
    Adamietz IA; Kurfürst F; Müller U; Renner K; Rimpler M
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1837-41. PubMed ID: 2632265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The topography of some anionic sites at the surfaces of fixed Ehrlich ascites tumour cells.
    Weiss L; Jung OS; Zeigel R
    Int J Cancer; 1972 Jan; 9(1):48-56. PubMed ID: 5062746
    [No Abstract]   [Full Text] [Related]  

  • 60. Activity of bleomycin in iron- and copper-deficient cells.
    Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH
    Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.